Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Oseltamivir analog with boron cluster modulator.

Adamska A, Olejniczak AB, Zwoliński K, Szczepek WJ, Król E, Szewczyk B, Grynkiewicz G, Leśnikowski ZJ.

Acta Pol Pharm. 2012 Nov-Dec;69(6):1218-23.

PMID:
23285684
[PubMed - indexed for MEDLINE]
Free Article
2.

Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.

Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH.

J Am Chem Soc. 2007 Oct 3;129(39):11892-3. Epub 2007 Sep 12. No abstract available.

PMID:
17850083
[PubMed - indexed for MEDLINE]
3.

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.

Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

Bioorg Med Chem. 2012 Mar 15;20(6):2152-7. doi: 10.1016/j.bmc.2012.01.026. Epub 2012 Jan 26.

PMID:
22342267
[PubMed - indexed for MEDLINE]
4.

Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.

Carbain B, Collins PJ, Callum L, Martin SR, Hay AJ, McCauley J, Streicher H.

ChemMedChem. 2009 Mar;4(3):335-7. doi: 10.1002/cmdc.200800379.

PMID:
19156651
[PubMed - indexed for MEDLINE]
5.

Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.

Gong J, Xu W.

Curr Med Chem. 2008;15(30):3145-59. Review.

PMID:
19075659
[PubMed - indexed for MEDLINE]
6.

Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.

Liu Y, Jing F, Xu Y, Xie Y, Shi F, Fang H, Li M, Xu W.

Bioorg Med Chem. 2011 Apr 1;19(7):2342-8. doi: 10.1016/j.bmc.2011.02.019. Epub 2011 Feb 17.

PMID:
21382719
[PubMed - indexed for MEDLINE]
7.

Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.

Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM.

J Med Chem. 2010 Oct 28;53(20):7377-91. doi: 10.1021/jm100822f.

PMID:
20873795
[PubMed - indexed for MEDLINE]
8.

Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods.

D'Souza C, Kanyalkar M, Joshi M, Coutinho E, Srivastava S.

Biochim Biophys Acta. 2009 Sep;1788(9):1740-51. doi: 10.1016/j.bbamem.2009.04.014. Epub 2009 May 4.

PMID:
19397892
[PubMed - indexed for MEDLINE]
Free Article
9.

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA.

Antiviral Res. 2002 Aug;55(2):307-17.

PMID:
12103431
[PubMed - indexed for MEDLINE]
10.

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.

Lew W, Chen X, Kim CU.

Curr Med Chem. 2000 Jun;7(6):663-72. Review.

PMID:
10702632
[PubMed - indexed for MEDLINE]
11.

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.

Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU.

Antiviral Res. 1998 Feb;37(2):107-20.

PMID:
9588843
[PubMed - indexed for MEDLINE]
12.

Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.

Ilyushina NA, Seiler JP, Rehg JE, Webster RG, Govorkova EA.

PLoS Pathog. 2010 May 27;6(5):e1000933. doi: 10.1371/journal.ppat.1000933.

PMID:
20523902
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.

Molla A, Kati W, Carrick R, Steffy K, Shi Y, Montgomery D, Gusick N, Stoll VS, Stewart KD, Ng TI, Maring C, Kempf DJ, Kohlbrenner W.

J Virol. 2002 Jun;76(11):5380-6.

PMID:
11991966
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.

Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, Watts AG, Pilling P, Streltsov VA, Petric M, Liggins R, Barrett S, McKimm-Breschkin JL, Niikura M, Withers SG.

Science. 2013 Apr 5;340(6128):71-5. doi: 10.1126/science.1232552. Epub 2013 Feb 21.

PMID:
23429702
[PubMed - indexed for MEDLINE]
Free Article
15.

High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.

Ishikawa H, Suzuki T, Orita H, Uchimaru T, Hayashi Y.

Chemistry. 2010 Nov 8;16(42):12616-26. doi: 10.1002/chem.201001108. Erratum in: Chemistry. 2011 Oct 24;17(44):12227.

PMID:
20859964
[PubMed - indexed for MEDLINE]
16.

An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.

Bromfield KM, Gradén H, Hagberg DP, Olsson T, Kann N.

Chem Commun (Camb). 2007 Aug 14;(30):3183-5. Epub 2007 May 25.

PMID:
17653382
[PubMed - indexed for MEDLINE]
17.

Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.

Stanley M, Martin SR, Birge M, Carbain B, Streicher H.

Org Biomol Chem. 2011 Aug 21;9(16):5625-9. doi: 10.1039/c1ob05384a. Epub 2011 Jun 30.

PMID:
21720632
[PubMed - indexed for MEDLINE]
18.

Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.

Du QS, Wang SQ, Chou KC.

Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. Epub 2007 Aug 13.

PMID:
17707775
[PubMed - indexed for MEDLINE]
19.

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.

Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Babu YS, Bantia S, Elliott AJ, Montgomery JA.

J Med Chem. 2001 Dec 6;44(25):4379-92.

PMID:
11728184
[PubMed - indexed for MEDLINE]
20.

Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.

Magano J.

Chem Rev. 2009 Sep;109(9):4398-438. doi: 10.1021/cr800449m. Review. No abstract available.

PMID:
19537777
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk